MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

Tirzepatide

  • FDA Investigating Reports of Alopecia and Suicidal Ideation as Possible Weight-Loss Drug Side Effects
    FDA Investigating Reports of Alopecia and Suicidal Ideation as Possible Weight-Loss Drug Side Effects
    The FDA is also investigating reported side effects of aspiration.
    January 4, 2024BY A.C. Dahnke
  • FDA Approved Nearly 50 Percent More Drugs in 2023 Than in 2022
    FDA Approved Nearly 50 Percent More Drugs in 2023 Than in 2022
    Only 2018 featured a higher number of drug approvals.
    January 3, 2024BY A.C. Dahnke
  • Stopping Treatment With Popular New Weight-Loss Drug May Lead to Regained Weight
    Stopping Treatment With Popular New Weight-Loss Drug May Lead to Regained Weight
    However, about 17 percent of individuals prescribed a placebo kept about 80 percent of their original weight loss, ...
    December 16, 2023BY A.C. Dahnke
  • Safety Concerns Loom as Obesity Drugs Head to Clinical Trials in Kids as Young as 6
    Safety Concerns Loom as Obesity Drugs Head to Clinical Trials in Kids as Young as 6
    As childhood obesity rates surge globally, pharma giants test weight loss drugs on kids despite safety concerns over ...
    November 1, 2023BY Mary Gillis
  • FDA Urges Online Vendors to Stop Sale of Unapproved Weight Loss Drugs
    FDA Urges Online Vendors to Stop Sale of Unapproved Weight Loss Drugs
    The U.S. Food and Drug Administration has urged online vendors to stop selling unapproved semaglutide and tirzepatide drugs ...
    October 11, 2023BY Lorenz Duchamps
  • UK Public Agency Won’t Recommend Weight Loss Drug Mounjaro, Needs More Evidence
    UK Public Agency Won’t Recommend Weight Loss Drug Mounjaro, Needs More Evidence
    UK's health and social care watchdog has decided against recommending Mounjaro, Eli Lilly's weight loss drug for adults with diabetes. ...
    June 28, 2023BY Harry Lee
TOP NEWS
  • DOJ Says Agencies Should Prioritize English Over Other Languages
    NEW By Jack Phillips
    DOJ Says Agencies Should Prioritize English Over Other Languages
  • Kremlin Says Europe Must Show Readiness to Contribute to Peace Process Before Joining Talks
    NEW By Victoria Friedman
    Kremlin Says Europe Must Show Readiness to Contribute to Peace Process Before Joining Talks
  • New White House Chief of Staff Imposes Restrictions on Meeting With Lobbyists
    3hr By Zachary Stieber
    New White House Chief of Staff Imposes Restrictions on Meeting With Lobbyists
  • Microsoft Outlook Emails Approaching Normal Levels After Outage, Company Says
    3hr By Jack Phillips
    Microsoft Outlook Emails Approaching Normal Levels After Outage, Company Says
  • Trump-Ordered Vaccine Safety Report Delayed Past Deadline
    3hr By Zachary Stieber
    Trump-Ordered Vaccine Safety Report Delayed Past Deadline
  • Global Oil Market Shows First Signs of Rebalancing as Gulf Exports Recover: IEA
    3hr By Evgenia Filimianova
    Global Oil Market Shows First Signs of Rebalancing as Gulf Exports Recover: IEA
  • Alleged Chinese Spy Alice Huang Linked to Huawei Data Center: Report
    4hr By Frank Fang
    Alleged Chinese Spy Alice Huang Linked to Huawei Data Center: Report
  • Bessent Blames Commerce Department for Failure to Blacklist Megaspeed
    4hr By Andrew Moran
    Bessent Blames Commerce Department for Failure to Blacklist Megaspeed
  • US Denies Iran’s Claim It Destroyed Radar in Bahrain
    5hr By Evgenia Filimianova
    US Denies Iran’s Claim It Destroyed Radar in Bahrain
  • IRS Collected Over $5.5 Trillion in Federal Taxes in 2026
    5hr By Naveen Athrappully
    IRS Collected Over $5.5 Trillion in Federal Taxes in 2026
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top